-
EP2668295
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2668295
| EP2668295 - METHODS OF DETECTING LUNG CANCER [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 16.12.2016 Database last updated on 03.09.2024 | Most recent event Tooltip | 16.12.2016 | Application deemed to be withdrawn | published on 18.01.2017 [2017/03] | Applicant(s) | For all designated states Cepheid 904 Caribbean Drive Sunnyvale, CA 94089 / US | [2013/49] | Inventor(s) | 01 /
MICHOT, Bernard Cepheid Europe S.A. Vira Solelh F-81470 Maurens-Scopont / FR | 02 /
DELFOUR, Olivier Cepheid Europe S.A. Vira Solelh F-81470 Maurens-Scopont / FR | [2013/49] | Representative(s) | Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [2013/49] | Application number, filing date | 12739259.5 | 26.01.2012 | WO2012US22756 | Priority number, date | US201161397729P | 26.01.2011 Original published format: US 201161397729 P | US201161436399P | 26.01.2011 Original published format: US 201161436399 P | US201161525008P | 18.08.2011 Original published format: US 201161525008 P | [2013/49] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2012103355 | Date: | 02.08.2012 | Language: | EN | [2012/31] | Type: | A2 Application without search report | No.: | EP2668295 | Date: | 04.12.2013 | Language: | EN | The application published by WIPO in one of the EPO official languages on 02.08.2012 takes the place of the publication of the European patent application. | [2013/49] | Search report(s) | International search report - published on: | US | 13.03.2014 | (Supplementary) European search report - dispatched on: | EP | 11.12.2015 | Classification | IPC: | G01N33/48, C12Q1/68 | [2016/02] | CPC: |
C12Q1/6886 (EP,CN,US);
C12Q2600/118 (US);
C12Q2600/158 (EP,CN,US);
C12Q2600/16 (US);
C12Q2600/178 (EP,CN,US)
|
| Former IPC [2014/19] | G01N33/48 | ||
| Former IPC [2013/49] | C12Q1/68 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2013/49] | Title | German: | VERFAHREN FÜR DEN NACHWEIS VON LUNGENKREBS | [2013/49] | English: | METHODS OF DETECTING LUNG CANCER | [2013/49] | French: | PROCÉDÉS DE DÉTECTION DU CANCER DU POUMON | [2013/49] | Entry into regional phase | 23.08.2013 | National basic fee paid | 23.08.2013 | Search fee paid | 23.08.2013 | Designation fee(s) paid | 23.08.2013 | Examination fee paid | Examination procedure | 23.08.2013 | Examination requested [2013/49] | 17.10.2014 | Amendment by applicant (claims and/or description) | 19.07.2016 | Application deemed to be withdrawn, date of legal effect [2017/03] | 26.08.2016 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2017/03] | Fees paid | Renewal fee | 27.03.2014 | Renewal fee patent year 03 | 27.01.2015 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 31.01.2014 | 03 M06 Fee paid on 27.03.2014 | 31.01.2016 | 05 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI]WO2010139810 (FEBIT HOLDING GMBH [DE]; KELLER ANDREAS [DE]; MEESE ECKART [DE]; BORRI) [X] 1,2,4,6,8,10 * claims 1-5,17,23,24 * * page 5, paragraph 1 * * page 7, paragraph 2 - page 8, paragraph 2 * [I] 3,5,7,9,11-13; | [XI]US2010010072 (DMITROVSKY ETHAN [US] ET AL) [X] 1,5-13 * paragraphs [0016] - [0019] - [0022] , [0073] - [0076] - [0205] , [0229] , [0233] - [0306] * * examples 6-10 * * figures 6-16 * * sequences 1,9 * [I] 2-4; | [X]WO2010083464 (CEPHEID [US]; SVANHOLM BARRIE CECILIA [SE]; DELFOUR OLIVIER [FR]; PERS) [X] 11-13 * examples 6-7 * * tables 11,12 *; | [X]WO2005024061 (CANCER REC TECH LTD [GB]; KRUDE TORSTEN [GB]; CHRISTOV CHRISTO [GB]; S) [X] 11-13 * page 13, paragraphs 3, last - page 14 * * claims 12,17 * * figure 12E *; | [XI] - GAO W ET AL, "Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis", BIOMEDICINE AND PHARMACOTHERAPY, ELSEVIER, FR, vol. 64, no. 6, ISSN 0753-3322, (20100701), pages 399 - 408, (20100225), XP027122806 [X] 1,4,8-13 * the whole document * * table 2 * [I] 5-7 | [A] - GLEN REID ET AL, "Circulating microRNAs: Association with disease and potential use as biomarkers", CRITICAL REVIEWS IN ONCOLOGY / HEMATOLOGY, ELSEVIER SCIENCE IRELAND LTD., LIMERICK, IE, vol. 80, no. 2, doi:10.1016/J.CRITREVONC.2010.11.004, ISSN 1040-8428, (20101109), pages 193 - 208, (20101115), XP028314259 [A] 1-13 * paragraphs [2.1.2] , [ 2.6] * * table 5 * DOI: http://dx.doi.org/10.1016/j.critrevonc.2010.11.004 | International search | [Y]US2010233704 (MICHOT ET AL.); | [Y] - KOTAKE ET AL., "Splicing factor SF3b as a target of the antitumor natural product pladeinolide", NTURE CHEM. BIOL., (200709), vol. 3, no. 9, pages 570 - 575, XP002599258 DOI: http://dx.doi.org/10.1038/NCHEMBIO.2007.16 | [A] - PERSSON ET AL., "Identification of New MicroRNAs in Paired Normal and Tumor Breast Tissue Suggests a Dual Role for the ERBB2/Her2 Gene", CANCER RES, (20110102), vol. 71, no. 1, pages 78 - 86, XP055031361 DOI: http://dx.doi.org/10.1158/0008-5472.CAN-10-1869 | [AP] - WATAHIKI ET AL., "MicroRNAs Associated with Metastatic Prostate Cancer", PLOS ONE, (20110930), vol. 6, no. 9, pages 1 - 13, XP055133095 DOI: http://dx.doi.org/10.1371/journal.pone.0024950 |